Fancy investing like Warren Buffett but unsure how to get started? One solution could be to buy into the Trojan Global Equity Fund. The fund's manager, Gabrielle Boyle, is herself an aficionado of Buffett's stock-picking techniques, writes Moira O'Neill at Investors Chronicle.
Boyle, who joined Troy Asset Management three years ago after 17 years at Lazard's, focuses on companies with strong brands and distribution channels. "We don't own cyclical businesses or companies that are dependent on one or two products," she tells O'Neill. Boyle also thinks buying and selling too many shares is a "tax" on investors, so she is sticking to a 20% annual turnover in the fund's portfolio.
Trojan Global Equity's remit is to deliver capital growth. It has performed well over one and five years, beating its benchmark and delivering a respective return of 17.9% and 70.1%. However, the three-year performance is less inspiring, with a 40.1% return underperforming the benchmark. Boyle says she was initially too cautious but is now comfortable with her 31 holdings, including favourites Colgate-Palmolive, Nestl and Microsoft.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Boyle has increased the fund's exposure to the US, Europe and Asia, notes Gary Jackson at Trustnet. Some 47% of the portfolio is now in the US, 20% in Europe and 5% in Asian stocks (with 20% in the UK). Major holdings include Swiss healthcare stocks Novartis and Roche. A recent strong performer has been US stock Fiserv, which provides electronic transactional services for US banks and had an upbeat investor presentation in June. The fund's ongoing charge is 1.12%.Contact: 020-7499 4030.
| Novartis | 5.7% |
| eBay | 5.1% |
| American Express | 4.9% |
| Becton Dickinson | 4.8% |
| Roche | 4.7% |
| Microsoft | 4.6% |
| Sage | 4.1% |
| Altria | 4.0% |
| Medtronic | 4.0% |
| Wells Fargo | 3.9% |
-
House prices rise 2.9% – will the recovery continue?House prices grew by 2.9% on an annual basis in September. Will Budget policies and ‘higher-for-longer’ rates dent the recovery?
-
Nvidia earnings: what to expectNvidia announces earnings after market close on 20 November. What should investors expect from the semiconductor giant?
